Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tesamorelin in Type 2 Diabetes
NCT01264497Phase 2Completed
- Sponsor
- Theratechnologies Inc.
- Start
- Feb 2002
- Primary completion
- Nov 2002
- Modality
- Peptides
01
Overview
A Phase 2 trial of tesamorelin in type 2 diabetes mellitus (T2DM), sponsored by Theratechnologies Inc.. Started Feb 2002; status: completed.
02
Drugs
tesamorelin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01264497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264497.